Neuroprotective Effects of Herbal Ethanol Extracts from Gynostemma pentaphyllum in the 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's Disease

被引:51
|
作者
Choi, Hyun Sook [1 ,2 ]
Park, Mi Sook [1 ,2 ]
Kim, Seung Hwan [3 ]
Hwang, Bang Yeon [1 ,2 ]
Lee, Chong Kil [1 ,2 ]
Lee, Myung Koo [1 ,2 ]
机构
[1] Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea
[2] Chungbuk Natl Univ, Res Ctr Bioresource & Hlth, Cheongju 361763, South Korea
[3] Kyung Hee Univ, Coll Phys Educ, Yongin 449701, South Korea
来源
MOLECULES | 2010年 / 15卷 / 04期
关键词
Gynostemma pentaphyllum; 6-hydroxydopamine-lesioned rats; tyrosine hydroxylase; dopamine; Parkinson's disease; L-DOPA; CUCURBITACEAE PLANTS; SAPONIN CONSTITUENTS; BRAIN; 6-OHDA; CELLS; IRON;
D O I
10.3390/molecules15042814
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
6-Hydroxydopamine administration for 28 days (8 mu g/2 mu L) reduced the number of tyrosine hydroxylase (TH)-immunopositive neurons to 40.2% in the substantia nigra compared to the intact contralateral side. Dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and norepinephrine levels were reduced to 19.1%, 52.3%, 47.1% and 67.4% in the striatum of 6-hydroxydopamine-lesioned rats compared to the control group, respectively. However, an oral administration of herbal ethanol extracts from Gynostemma pentaphyllum (GP-EX) (10 mg/kg and 30 mg/kg) starting on day 3 post-lesion for 28 days markedly ameliorated the reduction of TH-immunopositive neurons induced by 6-hydroxydopamine-lesioned rat brain from 40.2% to 67.4% and 75.8% in the substantia nigra. GP-EX administration (10 and 30 mg/kg) also recovered the levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and norepinephrine in post-lesion striatum to 64.1% and 65.0%, 77.9% and 89.7%, 82.6% and 90.2%, and 88.1% and 89.2% of the control group. GP-EX at the given doses did not produce any sign of toxicity such as weight loss, diarrhea and vomiting in rats during the 28 day treatment period and four gypenoside derivatives, gynosaponin TN-1, gynosaponin TN-2, gypenoside XLV and gypenoside LXXIV were identified from GP-EX. These results suggest that GP-EX might be helpful in the prevention of Parkinson's disease.
引用
收藏
页码:2814 / 2824
页数:11
相关论文
共 50 条
  • [41] Serotonin6 receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats
    Liu, Kun-Cheng
    Li, Jun-Yi
    Tan, Hui-Hui
    Du, Cheng-Xue
    Xie, Wen
    Zhang, Yu-Ming
    Ma, Wei-Lin
    Zhang, Li
    NEUROPHARMACOLOGY, 2015, 95 : 290 - 298
  • [42] Investigation of Neuroprotective Effects of Cyclooxygenase Inhibitors in the 6-Hydroxydopamine Induced Rat Parkinson Model
    Goren, Buelent
    Mimbay, Zehra
    Bilici, Nebahat
    Zarifoglu, Mehmet
    Ogul, Erhan
    Korfali, Ender
    TURKISH NEUROSURGERY, 2009, 19 (03) : 230 - 236
  • [43] Behavioral and morphological effects of minocycline in the 6-hydroxydopamine rat model of Parkinson's disease
    Quintero, Elias Matthew
    Willis, Lauren
    Singleton, Rachel
    Harris, Naida
    Huang, Peng
    Bhat, Narayan
    Granholm, Ann-Charlotte
    BRAIN RESEARCH, 2006, 1093 : 198 - 207
  • [44] Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease
    Crotty, S.
    Fitzgerald, P.
    Tuohy, E.
    Harris, D. M.
    Fisher, A.
    Mandel, A.
    Bolton, A. E.
    Sullivan, A. M.
    Nolan, Y.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 27 (02) : 294 - 300
  • [45] Neuroprotective effects of metabotropic glutamate receptor ligands in a 6-hydroxydopamine rodent model of Parkinson's disease
    Vernon, AC
    Palmer, S
    Datla, KP
    Zbarsky, V
    Croucher, MJ
    Dexter, DT
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 22 (07) : 1799 - 1806
  • [46] Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease
    Du, Xi-Xun
    Xu, Hua-Min
    Jiang, Hong
    Song, Ning
    Wang, Jun
    Xie, Jun-Xia
    NEUROSCIENCE BULLETIN, 2012, 28 (03) : 253 - 258
  • [47] Supplementation with Herbal Extracts to Promote Behavioral and Neuroprotective Effects in Experimental Models of Parkinson's Disease: A Systematic Review
    da Costa, Ianara Mendonca
    Lopes de Paiva Cavalcanti, Jose Rodolfo
    de Queiroz, Dinalva Brito
    de Azevedo, Eduardo Pereira
    Meneses do Rego, Amalia Cinthia
    Araujo Filho, Irami
    Parente, Paulo
    Botelho, Marco Antonio
    Guzen, Fausto Pierdona
    PHYTOTHERAPY RESEARCH, 2017, 31 (07) : 959 - 970
  • [48] Neuroprotective Effect of Pseudoginsenoside-F11 on a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine
    Wang, Jian Yu
    Yang, Jing Yu
    Wang, Fang
    Fu, Shi Yuan
    Hou, Yue
    Jiang, Bo
    Ma, Jie
    Song, Cui
    Wu, Chun Fu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [49] Morphologic changes within the cerebellar cortex in the unilateral 6-hydroxydopamine lesioned rat model for Parkinson disease
    Wu, Chenghua
    Fan, Guoguang
    Wu, Chunli
    Yu, Guibo
    Li, Zixuan
    HISTOLOGY AND HISTOPATHOLOGY, 2016, 31 (12) : 1337 - 1346
  • [50] Effects of graft pooling of foetal rat and mouse tissue and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's disease
    Schwarz, SC
    Sauer, H
    Oertel, WH
    Earl, CD
    Kupsch, AR
    EXPERIMENTAL BRAIN RESEARCH, 1997, 115 (01) : 71 - 82